Immuno-Regulatory Function of Indoleamine 2,3 Dioxygenase through Modulation of Innate Immune Responses

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Poormasjedi Meibod, Malihe Sadat ^a   Jalili, Raza B ^a   Hosseini Tabatabaei, Azadeh ^a   Hartwell, Ryan ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PERITONEUM MACROPHAGE; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; RAT; SKIN FIBROBLAST; T LYMPHOCYTE;

EID: 84881105896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071044     Document Type: Article

References (44)

1. Bach FH, (1998) Xenotransplantation: Problems and prospects. Annual Review of Medicine 49: 301-310.
2. Wennberg L, Rafael E, Liu J, Sundberg B, Wernersson A, et al. (1997) Allogeneic and xenogeneic islets are rejected by different and specific mechanisms: A study in rodents using a mixed allogeneic-xenogeneic islet transplantation model. Xenotransplantation 4: 228-234.
3. Lin Y, Vandeputte M, Waer M, (1997) Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 158: 5658-5667.
4. Schuurman HJ, Cheng J, Lam T, (2003) Pathology of xenograft rejection: a commentary. Xenotransplantation 10: 293-299.
5. Fox A, Mountford J, Braakhuis A, Harrison LC, (2001) Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol 166: 2133-2140.
6. Fox A, Koulmanda M, Mandel TE, van Rooijen N, Harrison LC, (1998) Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 66: 1407-1416.
7. Yi S, Hawthorne WJ, Lehnert AM, Ha H, Wong JK, et al. (2003) T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 170: 2750-2758.
8. Jalili RB, Forouzandeh F, Rezakhanlou AM, Hartwell R, Medina A, et al. (2010) Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. Diabetes 59: 2219-2227.
9. Yasuda H, Nagata M, Arisawa K, Yoshida R, Fujihira K, et al. (1998) Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest 102: 1807-1814.
10. Grohmann U, Bronte V, (2010) Control of immune response by amino acid metabolism. Immunol Rev 236: 243-264.
11. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
12. Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, et al. (2005) Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Clin Cancer Res 11: 6030-6039.
13. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, et al. (2002) Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 86: 1691-1696.
14. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, et al. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310: 850-855.
15. Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, et al. (2007) Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 293: H3415-3423.
16. Soliman H, Mediavilla-Varela M, Antonia S Indoleamine 2,3-dioxygenase: is it an immune suppressor? Cancer J 16: 354-359.
17. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
18. Dai H, Dai Z, (2008) The role of tryptophan catabolism in acquisition and effector function of memory T cells. Curr Opin Organ Transplant 13: 31-35.
19. Ito T, Yang M, Wang YH, Lande R, Gregorio J, et al. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204: 105-115.
20. Puccetti P, Fallarino F, (2008) Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 40: 101-105.
21. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR, (2008) The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 181: 5396-5404.
22. Forouzandeh F, Jalili RB, Germain M, Duronio V, Ghahary A, (2008) Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells. Mol Cell Biochem 309: 1-7.
23. Forouzandeh F, Jalili RB, Germain M, Duronio V, Ghahary A, (2008) Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts. Wound Repair Regen 16: 379-387.
24. Jalili RB, Forouzandeh F, Moeenrezakhanlou A, Rayat GR, Rajotte RV, et al. (2009) Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function. Am J Pathol 174: 196-205.
25. Jalili RB, Rayat GR, Rajotte RV, Ghahary A, (2007) Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts. J Cell Physiol 213: 137-143.
26. Li Y, Tredget EE, Ghaffari A, Lin X, Kilani RT, et al. (2006) Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol 126: 128-136.
27. Sandrin MS, Mulley WR, Li YD, Wee JL, Dodge N, et al. (2008) Local expression of IDO, either alone or in combination with CD40Ig, IL10 or CTLA4Ig, inhibits indirect xenorejection responses. Xenotransplantation 15: 174-183.
28. Salh B, Wagey R, Marotta A, Tao JS, Pelech S, (1998) Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J Immunol 161: 6947-6954.
29. Rezakhanlou AM, Habibi D, Lai A, Jalili RB, Ong CJ, et al. (2010) Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts. Biological Procedures Online 12: 107-112.
30. Li M, Moeen Rezakhanlou A, Chavez-Munoz C, Lai A, Ghahary A, (2009) Keratinocyte-releasable factors increased the expression of MMP1 and MMP3 in co-cultured fibroblasts under both 2D and 3D culture conditions. Mol Cell Biochem 332: 1-8.
31. Munn DH, Sharma MD, Baban B, Harding HP, Zhang YH, et al. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22: 633-642.
32. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
33. Miki T, Sun H, Lee Y, Tandin A, Kovscek AM, et al. (2001) Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc 33: 129-130.
34. Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, et al. (2006) Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 36: 690-700.
35. Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Herve C, et al. (2007) CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 117: 1096-1106.
36. Wee JL, Christiansen D, Li YQ, Boyle W, Sandrin MS, (2008) Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase. Immunol Cell Biol 86: 460-465.
37. Cadili A, Kneteman N, (2008) The role of macrophages in xenograft rejection. Transplant Proc 40: 3289-3293.
38. Lee GK, Park HJ, Macleod M, Chandler P, Munn DH, et al. (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107: 452-460.
39. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, et al. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114: 280-290.
40. Van der Vliet A, Smith D, O'Neill CA, Kaur H, Darley-Usmar V, et al. (1994) Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 303 (Pt 1): 295-301.
41. Worrall NK, Boasquevisque CH, Botney MD, Misko TP, Sullivan PM, et al. (1997) Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 63: 1095-1101.
42. Langrehr JM, Murase N, Markus PM, Cai X, Neuhaus P, et al. (1992) Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 90: 679-683.
43. Vos IH, Joles JA, Schurink M, Weckbecker G, Stojanovic T, et al. (2000) Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection. Eur J Pharmacol 391: 31-38.
44. Sekkai D, Guittet O, Lemaire G, Tenu JP, Lepoivre M, (1997) Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite. Arch Biochem Biophys 340: 117-123.